GILEAD SCIENCES, INC. - Director's Dealing 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-08-10

Reporting Person: Meyers James R (EVP Worldwide Commercial Ops)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-10	Common Stock	M	820	—	Acquired	3535	Direct
2017-08-10	Common Stock	F	295	$72.70	Disposed	3240	Direct
2017-08-10	Common Stock	G	525	—	Disposed	2715	Direct
2017-08-10	Common Stock	G	525	—	Acquired	126030	Indirect

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-10	Restricted Stock Unit	$	M	820	Disposed		Common Stock (820)	Direct

F1: The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.

F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3: Shares gifted to family trust.